Nintedanib is primarily used to manage various types of interstitial lung diseases, including idiopathic pulmonary fibrosis (IPF), chronic fibrosing interstitial lung diseases (ILDs) with a progressive phenotype, and systemic sclerosis-associated interstitial lung disease (SSc-ILD). It belongs to the class of tyrosine kinase inhibitors.
Diarrhoea
Nausea
Abdominal pain
Vomiting
Decreased appetite
Nintedanib is a Tyrosine Kinase Inhibitor.
It works by obstructing the activity of certain enzymes known as tyrosine kinases. Specifically, it targets those involved in the signalling pathways of Vascular Endothelial Growth Factor Receptor (VEGFR), Fibroblast Growth Factor Receptor (FGFR), and Platelet-Derived Growth Factor Receptor (PDGFR). By inhibiting these enzymes, Nintedanib helps to reduce inflammation and scarring (also called fibrosis), and slows down the abnormal growth of blood vessels in the lungs. This action helps to slow down the progression of interstitial lung diseases.
BDS, MDS
BMS, FMC, MD Resident
Most side effects are temporary and generally harmless and resolve when discontinuing this medicine. However, if you experience any severe side effects or worsening of any of the symptoms, please consult your doctor.
Frequently asked questions
No, Nintedanib is not a steroid. It is an anti-fibrotic drug classified as a tyrosine kinase inhibitor.
The research data does not specify any impact of Nintedanib on sleep. However, individual patient experiences may vary. If any sleep disturbances are noticed while taking Nintedanib, it should be discussed with the doctor.
Nintedanib may potentially harm the foetus if given to pregnant women. Women of reproductive age are advised to use highly effective contraception during treatment and for at least 3 months after the last dose of Nintedanib.
Nintedanib should be taken as advised by your doctor. The usual recommended dosage is twice daily.
The exact time for Nintedanib to show its effect can vary between individuals and depends on the specific condition being managed.
Nintedanib should be taken orally twice daily, approximately 12 hours apart, with food, or as instructed by your doctor.
Yes, weight loss is one of the common side effects associated with Nintedanib.
Subscribe
Claim your complimentary health and fitness tips subscription and stay updated on our newest promotions.
Download Truemeds
Manage your health with ease Download Truemeds today!Get easy access to medicine refills, health information, and more. With our app, you'll never have to wait in line again. Download now and start taking control of your health.
Contact Us
Our customer representative team is available 7 days a week from 9 am - 9 pm.
v3.5.2
Our Payment Partners